Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Social Indicators Research
|
June 26, 2023
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians
Alessandra De Rose, Maria Felice Arezzo, Mario Amore, et al.
Bipolar Disorders
|
January 20, 2016
Gray and white matter trajectories in patients with bipolar disorder
Gabriele Sani, Chiara Chiapponi, Fabrizio Piras, et al.
The Journal of Headache and Pain
|
October 16, 2008
The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers
Marco Innamorati, Maurizio Pompili, Sergio De Filippis, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 4, 2012
An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite
Matteo Caloro, Luana Lionetto, Ilaria Cuomo, et al.
Clinical Drug Investigation
|
June 2, 2019
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review
Chiara Rapinesi, Georgios D Kotzalidis, Lorenzo Mazzarini, et al.
Expert Opinion on Pharmacotherapy
|
November 18, 2022
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice
Andrea Fiorillo, Alessandro Cuomo, Gaia Sampogna, et al.
Advances in Therapy
|
May 26, 2017
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study
Marco Di Nicola, Sergio De Filippis, Giovanni Martinotti, et al.
Rivista Di Psichiatria
|
May 17, 2016
Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs)
Roberto Brugnoli, Chiara Rapinesi, Georgios D Kotzalidis, et al.
Clinical Neuropharmacology
|
January 29, 2016
Development of Hiccup in Male Patients Hospitalized in a Psychiatric Ward: Is it Specifically Related to the Aripiprazole-Benzodiazepine Combination?
Matteo Caloro, Daniela Pucci, Giuseppa Calabrò, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 6, 2023
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
Stefania Chiappini, Giacomo d'Andrea, Sergio De Filippis, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Social Indicators Research
|
June 26, 2023
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians
Alessandra De Rose, Maria Felice Arezzo, Mario Amore, et al.
Bipolar Disorders
|
January 20, 2016
Gray and white matter trajectories in patients with bipolar disorder
Gabriele Sani, Chiara Chiapponi, Fabrizio Piras, et al.
The Journal of Headache and Pain
|
October 16, 2008
The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers
Marco Innamorati, Maurizio Pompili, Sergio De Filippis, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 4, 2012
An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite
Matteo Caloro, Luana Lionetto, Ilaria Cuomo, et al.
Clinical Drug Investigation
|
June 2, 2019
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review
Chiara Rapinesi, Georgios D Kotzalidis, Lorenzo Mazzarini, et al.
Expert Opinion on Pharmacotherapy
|
November 18, 2022
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice
Andrea Fiorillo, Alessandro Cuomo, Gaia Sampogna, et al.
Advances in Therapy
|
May 26, 2017
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study
Marco Di Nicola, Sergio De Filippis, Giovanni Martinotti, et al.
Rivista Di Psichiatria
|
May 17, 2016
Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs)
Roberto Brugnoli, Chiara Rapinesi, Georgios D Kotzalidis, et al.
Clinical Neuropharmacology
|
January 29, 2016
Development of Hiccup in Male Patients Hospitalized in a Psychiatric Ward: Is it Specifically Related to the Aripiprazole-Benzodiazepine Combination?
Matteo Caloro, Daniela Pucci, Giuseppa Calabrò, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 6, 2023
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
Stefania Chiappini, Giacomo d'Andrea, Sergio De Filippis, et al.
Page
of 7